External reference pricing in the pharmaceuticals price regulation
Journal Title: Фармацевтичний журнал - Year 2014, Vol 6, Issue 6
Abstract
Regulation of drug prices is an important part of regulation of the pharmaceutical market, and requires a rationalization and systematic approach. Study of the application of an external reference pricing (ERP) should be the basis for the implementation of new legislative initiatives to avoid negative consequences on the availability of essential drugs. In order to study the experience of using ERP in different countries, learn the advantages and disadvantages of this method search and analysis of foreign literature have been made. Analysis showed that the ERP is one of the methods of a direct price control and is widely used in the EU. The majority of the EU and the OECD countries used ERP for the price regulation of patented medicines. At the same time, the method has a number of shortcomings and difficulties in the choice of reference countries, obtaining reliable and relevant information about the prices of medicines and may have negative effect on the availability of medicines. The main components of the method are: the choice of reference countries, the calculation of the reference price, the parallel use of other approaches to determine the price. The real impact of the ERP application have not been studied enough, so international experts consider the further study of the influence ERP on the pharmaceutical market essential. In developed countries, the price of drugs is based on multi-criteria approach, and the ERP is just one of many criteria. Effectiveness of the ERP as other methods of price regulation should be discussed in the context of healthcare system of the country, availability of drugs, physical and economic access to drugs, equitable access and rational use of drugs; the long-term prospects for the whole country as well as unexpected consequences that may occur should be considered.
Authors and Affiliations
A. Kheilomskyi, N. О. Datsiuk, I. Zhogov, S. Bilokobylsky
Development and validation of the methods of phenytoin determination in urine by the method of gas–liquid chromatography
Development of the methods of strong medicines determination in human biological liquids for application in forensic and clinical toxicology is one of actual problems of pharmaceutical science, but validation of the anal...
Pharmaceutical aspects of photometric analysis of drugs
Problems of improving ways to assess the quality of medicines currently apply to all sections of the pharmacopoeia analysis, due to the revision of traditional approaches to identifying, testing for purity, the determina...
Amino acids composition of herb of Lamiaceae family representatives
Researching of the amino acids contents in medicinal plant raw materials is an important task of pharmaceutical science and practice, because complexes of amino acids used for the corrections of hepatobiliary disorders,...
Pharmaceutical and medical law: control mode for the medicines for alcohol addiction pharmacotherapy
Prolonged alcohol abuse leads to an annual 2.5 million of deaths, generates negative social, economic and medical problems. Caused by alcohol, harm goes beyond the physical and mental health needs in the complex treatmen...
Stability studying of antral film-coated tablets
Stability studying is very important in process of development of finished drug products. Stability of drugs provides saving of theirs therapeutical properties during several years of shelf life. Stability should be unde...